நிறுவனம் ஆஃப் மீளுருவாக்கம் மருந்து News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from நிறுவனம் ஆஃப் மீளுருவாக்கம் மருந்து. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In நிறுவனம் ஆஃப் மீளுருவாக்கம் மருந்து Today - Breaking & Trending Today

Piedmont Animal Health to collaborate with Wake Forest to help treat cats with kidney disease

by Chantal Allam, NCBiotech Writer April 16, 2021 .
GREENSBORO A brighter future for cats suffering from chronic kidney disease (CKD) could be on the horizon.
Greensboro-based Piedmont Animal Health, which develops, licenses and markets animal-health therapeutics, has teamed up with Wake Forest University’s Institute of Regenerative Medicine (WFIRM) to develop a novel therapy targeting the progressive and debilitating condition.
Often seen in older cats, there are currently no available treatments for CKD.
“With WFIRM in our backyard, and a combined interest in raising the standard of care, it was natural for the two of us to work together,” said Doug Hepler, Ph.D., Piedmont’s chief scientific officer. ....

North Carolina , United States , New South Wales , Wake Forest University , Julie Bennington , Michael Kelly , Doug Hepler , Nancy Johnston , Koudy Williams , Piedmont Animal Health , Institute Of Regenerative Medicine , Carolina Biotechnology Center , Ncbiotech Piedmont Triad Advisory Committee , Ncbiotech Piedmont Triad Office , Regenerative Medicine , Veterinary Science , North Carolina Biotechnology Center , Talu Ventures , Piedmont Triad , Piedmont Triad Advisory Committee , வடக்கு கரோலினா , ஒன்றுபட்டது மாநிலங்களில் , புதியது தெற்கு வேல்ஸ் , எழுந்திரு காடு பல்கலைக்கழகம் , ஜூலி பென்னிங்டன் , மைக்கேல் கெல்லி ,

EMERCell Signs Strategic Partnership with Onward Therapeutics for the Development of its NK Cell Therapy Technology

(1)
EMERCell, a biotechnology company developing immunotherapies and cell-based therapies for oncology targets through to pharmaceutical development, announces the signature of a strategic partnership with Onward Therapeutics. The significant investment, of a confidential amount, will be made in three instalments that will allow EMERCell to reach the first human clinical trials.
We are delighted to partner with Onward Therapeutics, whose teams have recognized expertise in the development of new drugs in oncology and with whom we have strong synergies. Their participation is a recognition of our expertise and will allow us to accelerate our development, said Patrick Henno, founder and Chairman of EMERCell. ....

Patrick Henno , Kostenloser Wertpapierhandel , Caroline Carmagnol , University Hospital Of Montpellier , Institute Of Regenerative Medicine , Saint Eloi University Hospital Center , University Of Montpellier , Onward Therapeutics , University Hospital , Regenerative Medicine , Natural Killer , Occitanie Region , பல்கலைக்கழகம் மருத்துவமனை ஆஃப் மான்ட்பெல்லியர் , நிறுவனம் ஆஃப் மீளுருவாக்கம் மருந்து , பல்கலைக்கழகம் ஆஃப் மான்ட்பெல்லியர் , தொடர்ந்து சிகிச்சை , பல்கலைக்கழகம் மருத்துவமனை , மீளுருவாக்கம் மருந்து , இயற்கை கில்லர் , ஒக்ஸிததனிே பகுதி ,